Participant Trial Reports:
Vibration Therapy for Osteoporosis Research Incentive Program
The Vibration Therapy for Osteoporosis Research Incentive Program was launched in 2023 and began gaining visibility and participation in 2024. To date, 117 participants have registered for the program, and six of them have completed and submitted their research reports.
As part of our Osteoporosis Treatment Vibration Therapy Research Incentive Program, participants are invited to document how they use the VT007 vibration plate and submit anonymous reports on before-and-after DXA bone-density scans, training information, medications and supplements, lifestyle factors, and their own evaluation of the experience.
The reports below are presented as individual real-world observations. They are not controlled clinical trials and should not be interpreted as proof that vibration therapy caused the reported changes in bone mineral density (BMD). Participants may use medications, supplements, resistance exercise, dietary changes and other interventions at the same time. DXA equipment and testing conditions may also differ between scans.
Participant Report Cards
Report 2501 — Statistically Significant BMD Increases at the Lumbar Spine and Left Hip
Equipment: VT007 Vibration Plate
The participant reported using the vibration plate almost every day for nine minutes at 30 Hz while using the hand straps. The baseline DXA included measurements in the osteoporosis range at some skeletal sites. In the follow-up results, the lumbar-spine T-score was −1.6, the left femoral-neck T-score was −2.2 and the left total-hip T-score was −1.3, with the overall impression reported as osteopenia.
The imaging-provider comparison described the changes as statistically significant. Lumbar-spine BMD increased by 0.080 g/cm², reported as a 10.6% increase, while left-hip BMD increased by 0.059 g/cm², reported as an 8.2% increase. The participant believed that regular vibration-plate use played a major role in the improvement and planned to continue daily use. As with the other individual reports on this page, the observation does not by itself establish how much of the BMD change was caused by vibration therapy.
Report 2502 — Two Years of Regular Vibration Use
Equipment: VT007 Vibration Plate
The participant reported continuous use of the vibration plate for 10–20 minutes per day at 30–32 Hz together with multiple bone-health supplements. The submitted DXA report contains measurements from 2023, 2024 and 2025. Lumbar-spine BMD increased from 0.872 g/cm² in 2023 to 1.004 in 2024 and 1.090 in 2025. The lumbar-spine T-score changed from −2.6 to −1.5 and then −0.8.
Hip measurements also improved over the two-year period. For example, left femoral-neck BMD increased from 0.842 to 0.912 g/cm² and left total-hip BMD from 0.887 to 0.962 g/cm². The 2025 report's overall assessment was osteopenia, based on the lowest measured site, even though the lumbar-spine measurement was within the normal range.
Report 2508 — Improved Hip and Spine BMD Reported
Equipment: VT007 Vibration Plate
This participant followed a broad bone-loading exercise program that included vibration-assisted squats, heel drops and standing, together with resistance exercises, jumping and walking. The submitted August 2025 DXA report recorded a femoral-neck T-score of −2.4, total-hip T-score of −1.4 and lumbar-spine T-score of −3.1.
The radiology report states that, compared with the most recent comparable prior study, bone density increased 5.7% at the left hip and 15.9% at the spine. Because the participant was performing numerous other exercises and the report specifically notes limitations associated with different scan models, the observed changes cannot be attributed to vibration alone.
Report 2510 — Hip Improvement with Mixed Spine Result
Equipment: VT007 Vibration Plate
The participant documented a relatively active vibration-assisted training program using the VT007 at 30 Hz on the low-amplitude setting. Squats, L-squats, deadlifts, lunges and upper-body plank/push-up positions were performed on the plate. The participant also reported conventional weight training, impact training, hiking and daily walking.
The results were mixed by skeletal site. The participant wrote that the new DXA showed improvement in the hips while the spine worsened. This report is particularly useful because it demonstrates that changes in BMD do not necessarily occur uniformly throughout the skeleton.
There were also important concurrent interventions: supplements, increased dietary protein, creatine, collagen peptides, regular resistance/impact exercise and hormone-replacement therapy beginning during the observation period. The participant also noted that the follow-up DXA was performed on a different machine.
Report 2511A — Significant Improvement Reported by the DXA Provider
Equipment: VT007 Vibration Plate
This participant began with severe osteoporosis, including an October 2024 AP-spine T-score of −4.5. In November 2025, the follow-up DXA report showed an AP-spine T-score of −3.8, femoral-neck T-scores of −2.5 on both sides, left total-hip T-score of −1.0 and right total-hip T-score of −1.9.
The healthcare-provider report explicitly described the bone density as showing significant improvement. Its comparison section reported a 15.0% increase at the AP spine, 20.7% at the left total hip and 22.9% at the right total hip. The participant reported that 32 Hz was the preferred vibration setting. The submitted material does not provide enough information to isolate vibration from other possible influences, so these results should be viewed as an individual observation rather than a treatment-effect estimate.
Report 2511B — 13.2% Femoral-Neck and 11.4% Spine BMD Increase
Equipment: VT007 Vibration Plate
The participant's DXA report provides direct before-and-after BMD values. Left femoral-neck BMD increased from 0.514 to 0.581 g/cm², an interval increase of 13.2% reported by the imaging provider. Lumbar-spine BMD increased from 0.589 to 0.656 g/cm², an interval increase of 11.4%. The corresponding T-scores improved from −3.0 to −2.4 at the femoral neck and from −4.2 to −3.6 at the lumbar spine.
The participant used the VT007 regularly at 35 Hz, generally for about 10 minutes each day, alternating several standing and exercise positions. This participant also reported weight training and walking, hormone therapy, calcium, vitamin D, vitamin K2, magnesium and other supplements, and increased protein and collagen intake. In the participant's own evaluation, it was difficult to determine how much of the improvement should be attributed specifically to the vibration plate because several factors were changed at the same time.
What We Can Learn From These Reports
These participant reports show that real-world vibration therapy is rarely an isolated intervention. Participants commonly combine vibration with resistance or weight-bearing exercise, nutritional supplements, dietary changes and, in some cases, hormone therapy or other medical treatment. This makes individual reports unsuitable for establishing cause and effect, but it also makes detailed documentation especially valuable.
Several submitted reports show meaningful BMD improvement at one or more skeletal sites, while one report shows improvement at the hip accompanied by worsening at the spine. This variation is important. It suggests that efficacy should be evaluated by skeletal site and in relation to the complete treatment modality—including vibration frequency and amplitude, exercise pose, session duration, muscle loading and concurrent interventions.
As additional participants complete the program, a larger collection of consistently documented reports may help identify recurring patterns that can be examined more rigorously in future research.
About the Research Incentive Program
This is an open, participant-directed research incentive program sponsored by Vibration Therapeutic LLC. It is not a randomized or controlled clinical trial. Participants develop their own training plans according to their individual medical and physical conditions and are encouraged to consult appropriate healthcare professionals.
The program asks participants to provide before-and-after DXA reports and document their vibration-assisted exercise routine, vibration settings, medications and supplements, lifestyle factors and other relevant information. Personal identifying information is removed from reports published here.
Important Notice
These customer reports are observational and are presented for research and educational purposes. They do not establish that a vibration plate caused an increase or decrease in bone mineral density, and individual results should not be expected to predict results for another person. Vibration Therapeutic LLC is not a healthcare provider, and VT007 is sold as exercise equipment rather than as a medical device. People with osteoporosis, fractures or other medical conditions should consult an appropriate healthcare professional before beginning a new vibration or exercise program.
